K Martini1,2, C M Gygax3, C Benden4, A R Morgan5,6, G J M Parker5,6, T Frauenfelder7,3. 1. Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. katharina.martini@usz.ch. 2. University of Zurich, Zurich, Switzerland. katharina.martini@usz.ch. 3. University of Zurich, Zurich, Switzerland. 4. Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland. 5. Bioxydyn Limited, Manchester, UK. 6. Centre for Imaging Science, The University of Manchester, Manchester, UK. 7. Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Abstract
OBJECTIVES: To demonstrate, in patients with cystic fibrosis (CF), the correlation between three-dimensional dynamic oxygen-enhanced magnetic resonance imaging (OE-MRI) measurements and computed tomography Brody score (CF-CT) and lung function testing (LFT). METHODS: Twenty-one patients (median age, 25 years; female, n = 8) with a range of CF lung disease and five healthy volunteers (median age, 31 years; female, n = 2) underwent OE-MRI performed on a 1.5-T MRI scanner. Coronal volumes were acquired while patients alternately breathed room air and 100% oxygen. Pre-oxygen T1 was measured. Dynamic series of T1-weighted volumes were then obtained while breathing oxygen. T1-parameter maps were generated and the following OE-MRI parameters were measured: oxygen uptake (ΔPO2max), wash-in time and wash-out time. High-resolution CT and LFT were performed. The relationship between CF-CT, LFT and OE-MRI parameters were evaluated using Pearson correlation for the whole lung and regionally. RESULTS: Mean CF-CT was 24.1±17.1. Mean ΔPO2max and mean wash-in as well as skewness of wash-out showed significant correlation with CF-CT (ΔPO2max: r = -0.741, p < 0.001; mean wash-in: r = 0.501, p = 0.017; skewness of wash-out: r = 0.597, p = 0.001). There was significant correlation for the whole lung and regionally between LFT parameters and OE-MR (ΔPO2max: r = 0.718, p < 0.001; wash-in: r = -0.576, p = 0.003; wash-out skewness: r = -0.552, p = 0.004). CONCLUSIONS: Functional lung imaging using OE-MRI has the capability to assess the severity of CF lung disease and shows a significant correlation with LFT and CF-CT. KEY POINTS: • Oxygen-enhanced MRI might play a future role in evaluation and follow-up of cystic fibrosis. • Heterogeneity of parameter maps reflects localised functional impairment in cystic fibrosis. • Avoidance of cumulative radiation burden in CF is feasible using OE-MRI.
OBJECTIVES: To demonstrate, in patients with cystic fibrosis (CF), the correlation between three-dimensional dynamic oxygen-enhanced magnetic resonance imaging (OE-MRI) measurements and computed tomography Brody score (CF-CT) and lung function testing (LFT). METHODS: Twenty-one patients (median age, 25 years; female, n = 8) with a range of CF lung disease and five healthy volunteers (median age, 31 years; female, n = 2) underwent OE-MRI performed on a 1.5-T MRI scanner. Coronal volumes were acquired while patients alternately breathed room air and 100% oxygen. Pre-oxygen T1 was measured. Dynamic series of T1-weighted volumes were then obtained while breathing oxygen. T1-parameter maps were generated and the following OE-MRI parameters were measured: oxygen uptake (ΔPO2max), wash-in time and wash-out time. High-resolution CT and LFT were performed. The relationship between CF-CT, LFT and OE-MRI parameters were evaluated using Pearson correlation for the whole lung and regionally. RESULTS: Mean CF-CT was 24.1±17.1. Mean ΔPO2max and mean wash-in as well as skewness of wash-out showed significant correlation with CF-CT (ΔPO2max: r = -0.741, p < 0.001; mean wash-in: r = 0.501, p = 0.017; skewness of wash-out: r = 0.597, p = 0.001). There was significant correlation for the whole lung and regionally between LFT parameters and OE-MR (ΔPO2max: r = 0.718, p < 0.001; wash-in: r = -0.576, p = 0.003; wash-out skewness: r = -0.552, p = 0.004). CONCLUSIONS: Functional lung imaging using OE-MRI has the capability to assess the severity of CF lung disease and shows a significant correlation with LFT and CF-CT. KEY POINTS: • Oxygen-enhanced MRI might play a future role in evaluation and follow-up of cystic fibrosis. • Heterogeneity of parameter maps reflects localised functional impairment in cystic fibrosis. • Avoidance of cumulative radiation burden in CF is feasible using OE-MRI.
Entities:
Keywords:
Cystic fibrosis; Lung; Lung disease; MRI; Magnetic resonance imaging
Authors: Helen Marshall; Alex Horsley; Chris J Taylor; Laurie Smith; David Hughes; Felix C Horn; Andrew J Swift; Juan Parra-Robles; Paul J Hughes; Graham Norquay; Neil J Stewart; Guilhem J Collier; Dawn Teare; Steve Cunningham; Ina Aldag; Jim M Wild Journal: Thorax Date: 2017-03-06 Impact factor: 9.139
Authors: Claus Peter Heussel; Klaus K Gast; Anja Dahmen; Andreas E Morbach; Hans-Ulrich Kauczor; Wolfgang G Schreiber; Manfred Thelen; Edwin J R van Beek Journal: Med Klin (Munich) Date: 2005-07-15
Authors: Alan S Brody; Jeffrey S Klein; Paul L Molina; Joanne Quan; Judy A Bean; Robert W Wilmott Journal: J Pediatr Date: 2004-07 Impact factor: 4.406
Authors: Peter M Jakob; Tungte Wang; Georg Schultz; Helge Hebestreit; Alexandra Hebestreit; Dietbert Hahn Journal: Magn Reson Med Date: 2004-05 Impact factor: 4.668
Authors: Lucia Flors; John P Mugler; Eduard E de Lange; Grady W Miller; Jaime F Mata; Nick Tustison; Iulian C Ruset; F William Hersman; Talissa A Altes Journal: J Thorac Imaging Date: 2016-09 Impact factor: 3.000
Authors: Alan R Smyth; Scott C Bell; Snezana Bojcin; Mandy Bryon; Alistair Duff; Patrick Flume; Nataliya Kashirskaya; Anne Munck; Felix Ratjen; Sarah Jane Schwarzenberg; Isabelle Sermet-Gaudelus; Kevin W Southern; Giovanni Taccetti; Gerald Ullrich; Sue Wolfe Journal: J Cyst Fibros Date: 2014-05 Impact factor: 5.482
Authors: Eric W F W Alton; A Christopher Boyd; Jane C Davies; Deborah R Gill; Uta Griesenbach; Tracy E Harman; Stephen Hyde; Gerry McLachlan Journal: Hum Gene Ther Date: 2020-09 Impact factor: 5.695
Authors: Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen Journal: Lancet Respir Med Date: 2019-09-27 Impact factor: 30.700